These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22854688)

  • 1. [Relation of genetic variants of CYP2A6 with tobacco dependence and smoking habit in Chilean subjects. A pilot study].
    Cáceres DD; Alvarado SA; Martínez P; Quiñones LA
    Rev Med Chil; 2012 Apr; 140(4):436-41. PubMed ID: 22854688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers.
    O'Loughlin J; Paradis G; Kim W; DiFranza J; Meshefedjian G; McMillan-Davey E; Wong S; Hanley J; Tyndale RF
    Tob Control; 2004 Dec; 13(4):422-8. PubMed ID: 15564629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.
    Nakajima M
    Curr Opin Mol Ther; 2007 Dec; 9(6):538-44. PubMed ID: 18041664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CYP2A6 in the emergence of nicotine dependence in adolescents.
    Audrain-McGovern J; Al Koudsi N; Rodriguez D; Wileyto EP; Shields PG; Tyndale RF
    Pediatrics; 2007 Jan; 119(1):e264-74. PubMed ID: 17130279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analytic review of the CYP2A6 genotype and smoking behavior.
    Carter B; Long T; Cinciripini P
    Nicotine Tob Res; 2004 Apr; 6(2):221-7. PubMed ID: 15203795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
    Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
    Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An association of CYP2A6 genotype and smoking topography.
    Strasser AA; Malaiyandi V; Hoffmann E; Tyndale RF; Lerman C
    Nicotine Tob Res; 2007 Apr; 9(4):511-8. PubMed ID: 17454707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2A6 allele frequencies in an Iranian population.
    Emamghoreishi M; Bokaee HR; Keshavarz M; Ghaderi A; Tyndale RF
    Arch Iran Med; 2008 Nov; 11(6):613-7. PubMed ID: 18976031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort.
    Gambier N; Batt AM; Marie B; Pfister M; Siest G; Visvikis-Siest S
    Pharmacogenomics J; 2005; 5(4):271-5. PubMed ID: 15940289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in CYP2A6 are associated with a risk of cigarette smoking and predispose to smoking at younger ages.
    Pérez-Rubio G; López-Flores LA; Ramírez-Venegas A; Noé-Díaz V; García-Gómez L; Ambrocio-Ortiz E; Sánchez-Romero C; Hernández-Zenteno RJ; Sansores RH; Falfán-Valencia R
    Gene; 2017 Sep; 628():205-210. PubMed ID: 28734893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.
    Malaiyandi V; Sellers EM; Tyndale RF
    Clin Pharmacol Ther; 2005 Mar; 77(3):145-58. PubMed ID: 15735609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6?
    Verde Z; Santiago C; Rodríguez González-Moro JM; de Lucas Ramos P; López Martín S; Bandrés F; Lucia A; Gómez-Gallego F
    Pharmacopsychiatry; 2014 Jan; 47(1):33-6. PubMed ID: 24127329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population.
    Loriot MA; Rebuissou S; Oscarson M; Cenée S; Miyamoto M; Ariyoshi N; Kamataki T; Hémon D; Beaune P; Stücker I
    Pharmacogenetics; 2001 Feb; 11(1):39-44. PubMed ID: 11207029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking cessation program and CYP2A6 polymorphism.
    Ozaki S; Oyama T; Isse T; Kagawa N; Uramoto H; Sugio K; Yasumoto K; Kono K; Kawamoto T
    Front Biosci; 2006 Sep; 11():2590-7. PubMed ID: 16720336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional variants at CYP2A6: new genotyping methods, population genetics, and relevance to studies of tobacco dependence.
    Zabetian CP; Gelernter J; Cubells JF
    Am J Med Genet; 2000 Oct; 96(5):638-45. PubMed ID: 11054771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Smoking genes': a genetic association study.
    Verde Z; Santiago C; Rodríguez González-Moro JM; de Lucas Ramos P; López Martín S; Bandrés F; Lucia A; Gómez-Gallego F
    PLoS One; 2011; 6(10):e26668. PubMed ID: 22046326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema.
    Minematsu N; Nakamura H; Iwata M; Tateno H; Nakajima T; Takahashi S; Fujishima S; Yamaguchi K
    Thorax; 2003 Jul; 58(7):623-8. PubMed ID: 12832682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in CYP2A6 predicts neural reactivity to smoking cues as measured using fMRI.
    Tang DW; Hello B; Mroziewicz M; Fellows LK; Tyndale RF; Dagher A
    Neuroimage; 2012 May; 60(4):2136-43. PubMed ID: 22342802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
    Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
    Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
    Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
    Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.